Compare ARTL & SOPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARTL | SOPA |
|---|---|---|
| Founded | 2011 | 2018 |
| Country | United States | Singapore |
| Employees | 7 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.3M | 5.2M |
| IPO Year | N/A | 2021 |
| Metric | ARTL | SOPA |
|---|---|---|
| Price | $1.40 | $0.08 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | N/A | ★ $22.50 |
| AVG Volume (30 Days) | 801.0K | ★ 1.6M |
| Earning Date | 05-13-2026 | 05-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $8,171,635.00 |
| Revenue This Year | N/A | $2.43 |
| Revenue Next Year | N/A | $71.20 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 45.00 |
| 52 Week Low | $1.01 | $0.07 |
| 52 Week High | $28.60 | $6.28 |
| Indicator | ARTL | SOPA |
|---|---|---|
| Relative Strength Index (RSI) | 33.35 | 19.75 |
| Support Level | $1.08 | N/A |
| Resistance Level | $1.50 | $0.66 |
| Average True Range (ATR) | 0.23 | 0.04 |
| MACD | 0.04 | -0.02 |
| Stochastic Oscillator | 16.20 | 2.06 |
Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.
Society Pass Inc is building an ecosystem of platforms and technology-enabled companies that synergistically work together to transform how consumers and merchants interact with one another in Southeast Asia and South Asia. Through the acquisition of companies and partnerships with entrepreneurs, the company meets the growing demand for services in sectors such as lifestyle, beauty, travel, and food and beverage. The company currently operates in Six reportable operating segments: Online Grocery and Food deliveries, Digital marketing, Online ticketing and reservation, Telecommunications Reseller, e-commerce, and Corporate. The company generates the majority of its revenue from the Digital marketing segment.